2m 2m 2m 2m 2m 2m 2m
TRAWS PHARMA (TRAW)
NASDAQ
$0.38+$0.02 (+4.17%)
Price as of Oct 22, 2026 7:30 PM EDT- $5.8MMarket Cap
- -85.97%1-Year Change
- BiotechnologyIndustry
TRAWS PHARMA (TRAW)
$0.38+$0.02 (+4.17%)
TRAW | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.37 | ||
Change | -$0.0007 (-0.19%) | ||
Open | $0.37 | ||
High | $0.38 | ||
Low | $0.36 | ||
Previous Close | $0.38 | ||
Volume | 62,215 | ||
30-Day Average Volume | 1,434,038 | ||
1-Week Change | -6.28% | ||
1-Month Change | -24.77% | ||
1-Year Change | -85.97% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 15.4M | ||
Total Assets | $11.5M | ||
Market Cap | $5.8M | ||
Enterprise Value | $762,472.00 | ||
Period: QTR TTM FY | |||
Revenue | $2.7M | ||
Net Income | -$3.1M | ||
Free Cash Flow | -$7.5M | ||
EBIT | -$3.1M | ||
EBITDA | -$3.0M | ||
Net Working Capital | -$712,000.00 | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 0 | ||
P/B | 3 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 09/23/2024 | ||
Earnings & Revenue